Efficacy and Safety of Oral Cashew Nut Immunotherapy in Children (CAJESITO)
NCT ID: NCT05826405
Last Updated: 2023-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2023-05-10
2023-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Cashew Nut Oral Immunotherapy in Children
NCT05821621
Efficacy and Saffety of Oral Immunotherapy to Pistachio
NCT05698030
UNC Cashew Sublingual Immunotherapy
NCT07170540
Relevance of Sensitization to Legumes in Children Allergic to Peanut
NCT04329078
Threshold Dose Distribution for Pistachio Allergy
NCT06589232
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cashew Nut allergic
No intervention
No intervention, it's an observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention, it's an observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have received oral cashew nut immunotherapy for at least 18 months as of 02/28/2023
Exclusion Criteria
* Patients lost to follow-up for more than 3 years, i.e. last consultation dating from 2020 or earlier
0 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amandine DIVARET-CHAUVEAU
Principal investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FORM-03935
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.